EIRX unit applies for liquidation

EIRX Therapeutics, the Cork-based drug discovery firm, has applied to put its Irish unit into liquidation.

EIRX unit applies for liquidation

As part of the liquidation process its chief executive Colin Telfer has resigned as a director. Directors John Pool, Nick Strong and Tom Cotter are working to put together a plan which they hope will secure the future of the company based around its other operating business, Auvation Limited.

Investment vehicle Billam said it has decided to write off its investment in the group. In total, the group’s investment portfolio has therefore been reduced by £433,000 (€546,000), when also taking into account the company’s writeoff of its unquoted investment in Tri-Mex Group.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited